ACAS Logo Portfolio Company
BOSTON| CHICAGO| DALLAS| FRANKFURT| LONDON| LOS ANGELES| MADRID| NEW YORK| PALO ALTO| PARIS| WASHINGTON, DC

SHAREHOLDER UPDATES

Q1 2008 Shareholder Presentation

Investor Fact Sheet

2008 Proxy Statement

2007 Annual Report

American Capital Announces Tax Status of 2007 Dividends

AMERICAN CAPITAL NEWS

American Capital Declares $1.03 Q2 2008 Dividend Reports $0.77 NOI and $0.94 Realized Earnings in Q1 2008

American Capital Reorganizes Sponsor Finance Group: Opens Boston Office, Reorganizes Northeast and California

More American Capital News »

PRESS COVERAGE

American Capital Portfolio Company Confluence's new CEO aims to boost sales, The Greenville News

On the Record: Samuel Flax, Legal Times

More Press Coverage »

NEWSLETTER

American Capital Newsletter

STOCK RETURNS CALCULATOR

Calculate Returns On Your
American Capital Stock

ACAS Stock Returns

* Includes Dividends Reinvested

OUR PORTFOLIO

American Capital Portfolio Companies

Seroyal International Inc.

Visit Seroyal's website

American Capital Invests $20 Million in Leading Marketer, Distributor of Branded Nutritional Supplements & Naturopathic Medicines
Bethesda, MD - January 21, 2005 - American Capital Strategies Ltd. (Nasdaq:ACAS) announced today that in December 2004 it invested $20 million in Seroyal International Inc. and Seroyal USA Inc. (together, "Seroyal"), a leading marketer and distributor of branded nutritional supplements and homeopathic medicines to healthcare professionals in Canada and the U.S. American Capital's investment takes the form of a senior term loan B, senior subordinated debt and preferred and common equity and supports Bruckmann, Rosser, Sherrill & Co. LLC's ("BRS") recapitalization of Seroyal. Rosetta Raso, founder and owner of Seroyal, will continue to serve in her capacity as President and Chief Executive Officer of Seroyal. [more...]

 
 
tombstone